Two recent clinical trials have shown that a one-time voyage with psilocybin, the active component of psychedelic mushrooms, improved optimism, life-outlook and quality of life, while decreasing symptoms of an anxiety and depression in life-threatening cancer patients.
The results of the psilocybin trial have made waves in the scientific community, or at least for those who have never done mushrooms themselves. Eighty percent of patients displayed an immediate reduction in symptoms of anxiety and depression that lasted even after a six-month follow-up. These lasting effects make this treatment option very valuable as a potential replacement for traditional anti-anxiety and depression drugs.
The results of these two large clinical trials, in which over 50 cancer patients were legally administered psilocybin in controlled settings, validate the conclusions people in the psychedelic community have been saying for years. Hallucinogens, like psilocybin, LSD, mescaline, DMT, etc., cause transcendental, though sometimes fleeting, changes in the way an individual views his or her self and the world around them. When administered in the right set and setting, revelations and epiphanies that spring from altered thought processes help an individual grow past adversity and gain new-found serenity.
Participants in the studies, which took place at New York University and John Hopkins University, attributed improvements in mood and outlook to the high-dose experience, and less so to low-dose trials. This is in-line with the experience of tripping shrooms—a couple small caps and a stem is enough to give you a good buzz, but for a real spiritual experience, you need to go all in.
“Why are you letting yourself be terrorized by cancer coming back? This is dumb. It’s in your power to get rid of the fear,” he told himself. “That’s when I saw black smoke rising from my body. And it felt great,” Octavian Mihai told the New York Times in an interview about his experience. “I’m not anxious about cancer anymore. I’m not anxious about dying.” The experience, “has made my life richer.”
Participants drank a dose of psilocybin from an earthenware chalice and relaxed in a softly lit, pleasantly decorated room and listened to a specially-crafted, seven-hour playlist designed to reflect the pace of experience. In order to get the most out of the trip, doctors asked the patients to write down their visions and thoughts in a notebook during the trip. In addition to discussing what they experienced in meetings afterword, researchers were careful to make sure the participants remembered and reflected on the thoughts they had during their journeys.
These come at a time when psychedelics and other so-called “party drugs” like MDMA are gaining acceptance among psychologists, neuropsychopharmacologists and medical practitioners. With the approval of MDMA for final stages of clinical trials, and other clinical or exploratory trials with psilocybin for treating addiction and depression, psychedelics are just now “breaking through” into mainstream society.
As the scientific community opens up to these amazing substances, more people will open up their minds to the new ways of thinking they promote. At the very least, we could see some tie-dye lab coats in the very near future.
You can keep up with all of HIGH TIMES’ news right here.
(Photo Credit: NotTelkin)
How Many States Allow Medical Marijuana?
Navigating Canada’s Underground Edibles Scene With EP Infusions
Epileptic 5-Year-Old May Now Bring Cannabis-Based Medicine to School
Maine Restaurant Sedating Lobsters With Cannabis Under Investigation
Malaysian Court Sentences Man to Death for Distributing Free Cannabis Oil
Hot Pot Products: 4 Must-Haves for Cannabis Cultivators
Canadian Dispensary Clerk Fights off Three Burglars With a Giant Bong
Study Suggests CBD May Have Antipsychotic Effect in High-Risk Individuals
Guides6 days ago
What Do The Colors of Marijuana Mean?
News7 days ago
South African Court Rules Private, Adult-Use Cannabis is Legal
Celebrities6 days ago
Kristen Bell Opens Up About Weekly Cannabis Use and Exploring Other Drugs
Medical Marijuana7 days ago
Canadian Cannabis Company Tilray to Export Products to United States
News7 days ago
Woman Finds Package of Weed in Food Subscription Box
News5 days ago
First Clinical Trial of MDMA Treatment for Autistic Adults Sees Success
Strains5 days ago
9 Colorful Weed Strains To Brighten Your Day
News6 days ago
New Report Says Concentrates are the Fast Growing Favorite Among Consumers